Healthcare and Life Sciences teams map the patient journey to spot care gaps and guide interventions. However, clinical records cover only what happens inside clinics, not the forces driving patient decisions. Enriching these records with lifestyle, socioeconomic, and consumer-behavior insights reveals the “why” behind health outcomes. That’s where non-clinical insights step in – revealing the real-world forces that shape patient results.
To address these blind spots, Experian and Komodo Health have teamed to integrate de-identified insights from millions of patient journeys with Experian’s socioeconomic and lifestyle data. This enriched view lets enterprises see each journey in full, identify care disparities, and craft smarter strategies – while rigorously protecting privacy.
Driving tangible outcomes and better patient care
This collaboration focuses on turning insights into action. With Experian and Komodo’s integrated clinical, socioeconomic, and lifestyle data, Healthcare and Life Sciences teams can move from insight to accuracy, building adherence programs, finding hard-to-reach patients, and demonstrating treatment success.
They can:
- Layer Komodo’s de-identified patient-level medical and pharmacy insights and analytics with Experian lifestyle and socioeconomic attributes
- Segment patient populations by condition, treatment history, and socioeconomic status
- Prioritize outreach – reducing waste and focusing resources where care is needed most
For instance:
Neighborhood-level gaps
Identify opportunities to capture untreated patients and improve clinical trial inclusion.
Income-related support
Flag populations most likely to benefit from cost-saving programs, ensuring communications highlight co-pay assistance or financial relief options.
Inside the data stack
At the core of Komodo Health’s AI-enabled healthcare analytics platform is its Healthcare Map®. This innovative tool integrates de-identified patient-level medical and pharmacy claims data from the patient journeys of over 330 million unique individuals – providing insights on diagnoses, treatments, outcomes, and care patterns across the United States. Experian enhances this data by adding socioeconomic and lifestyle characteristics that influence up to 80% of health outcomes.
Together, this combined data effectively addresses essential questions such as:
- Which neighborhoods face the highest diabetes risk?
- Where is therapy abandonment spiking?
- When should co-pay assistance messages drop?
- How can we accelerate HCP outreach or clinical-trial recruitment?
Experian’s socioeconomic and lifestyle insights: Fueling data-driven care decisions
In this context, Experian provides valuable insights into socioeconomic factors and lifestyle patterns, covering everything from household composition and income ranges to psychographics and other attributes that help build a broader understanding of an individual’s circumstances.
Where deep patient understanding, health engagement, and real-world evidence converge
As healthcare marketing, patient engagement, and real-world data converge, the Experian and Komodo collaboration is empowering Healthcare and Life Sciences teams with fast, actionable insights. Fusing de-identified patient-level clinical data with socioeconomic and lifestyle attributes helps teams engage the right patients, and fuels research from product launches to community programs. It elevates experiences while proving impact with real-world evidence.
Ready to utilize these insights?
Latest posts
NEW YORK, Sept. 28, 2016 /PRNewswire/ – Tapad, the leader in cross-device marketing technology, today announced a new metric for cross-device marketers, Viewable Exposure Time (VET). Viewable Exposure Time measures across screens and ad formats, identifying the optimal amount of time a consumer spends with an ad before they take action. The announcement coincides with Unify Tech '16, Tapad's third-annual cross-device summit during Advertising Week NY. Frequency caps are currently used to ensure that dollars aren't wasted on redundant ads. Viewable Exposure Time evolves the frequency capping approach to include accelerating a consumer's ad exposure rate up to the optimal time spent with the brand. VET is used in affinity, digital transaction and offline purchase models as a key indicator of marketing budget well-spent. Beta users of VET span every vertical, though interest is especially high from CPG, Automotive, Telecommunications and Retail. Viewable Exposure Time unifies and upgrades marketers' predictors of advertising success by leveraging cross-screen engagement across digital and television, with vendor-agnostic viewability scores for video, rich media and display. "Today's current measurement options, like click-through rate (CTR) and TV gross ratings points (GRP) tell an incomplete story," said Tapad GM of Media Kate O'Loughlin. "Tapad is focused on measuring what really matters to marketers – building an efficient connection with a customer. Innovation in metrics was long overdue." More than just a measurement tool, Tapad also provides clients with VET activation. Factoring in time spent with ads in viewable seconds and minutes, these analytics inform marketers about which audiences are underexposed, enabling them to adjust campaigns and deliver according to optimal viewable exposure time. This effectively increases conversion rates at the lowest cost. Contact us today
Strong Revenue Performance and Thriving Culture Contribute to Industry Recognition NEW YORK, Sept. 15, 2016 /PRNewswire/ — Tapad, the leader in cross-device marketing technology and now a part of Experian, was named a top company on Inc. Magazine’s list of the 5000 fastest-growing private companies in the U.S. In addition, Tapad won the TMCnet 2016 Tech Culture Award. The exclusive Inc. 5000 ranking highlights the fastest-growing privately-held* companies in America. These distinguished companies have achieved success in strategy, service and innovation. TMCnet recognizes talented tech professionals who are committed to building a culture that prioritizes employee growth, collaboration and engagement. Tapad continues to broaden their presence into new markets, having launched in APAC earlier this year, as well as continuing their European expansion. Tapad’s proprietary technology, The Device Graph™ is leveraged by more marketers and brands to understand digital engagement across devices. The company’s rapidly expanding client base includes numerous Fortune 500 company brands as well as all four major advertising holding companies in the U.S. “We have an exceptional team of innovative people who are all working very hard to achieve the kind of results these publications are recognizing,” said Tapad CEO and Founder, Are Traasdahl. “Given that, we have an even greater responsibility to our talent to create an environment that fosters innovation and nurtures open communication. Ultimately, this is how we will continue to reach our very ambitious goals of becoming the world’s leading unified marketing technology provider.” Tapad’s award-winning work culture is defined by its gold-standard benefits which include a six-month parental leave policy, unlimited vacation time, company-sponsored meals and office space designed to facilitate collaboration and open communication. Tapad’s highly talented team has also received multiple customer service awards in 2016. These awards include the iMedia ASPY awards for Best Customer Service and Best Mobile Partner as well as recognition from The Communicator Awards of Excellence in Interactive Media. *Prior to Tapad’s acquisition by Telenor in February 2016. Contact us today
The Tapad Device GraphTM Had Twice the Precision and Three Times the Scale as Next Competitor New York, September 14, 2016 – Just-released findings of a Hotels.com® study revealed that Tapad’s (part of Experian) cross-screen marketing technology achieved the highest levels of precision and scale among competitors. According to the leading online accommodation booking website, after a rigorous, three-and-a-half month vendor analysis, Tapad achieved twice the precision of the next highest-scoring cross-screen offering and three times greater scale. The two other companies evaluated were not named. Said Helene Cameron-Heslop, Senior Manager of Analytics of the Hotels.com brand, “Our team implemented an extremely rigorous vetting of open, cross-screen technology vendors. At the outset, we assumed we would have to compromise on either scale or accuracy – particularly given the importance to our brand of operating in a privacy-safe setting. We were surprised to find a complete package, but Tapad’s Device Graph won out on scale, accuracy and privacy; making our choice of partners very clear.” In another metric critical to the Hotels.com brand, The Tapad Device GraphTM was eight times more “unique” than the next closest offering, meaning Tapad’s graph was found to have a much greater number of connections not seen in any of the other graphs. In addition to precision, uniqueness and scale, the Tapad Device GraphTM was found to have: ● 100% higher recall● 47% more incremental matches● 53% higher North American market coverage● 101% higher F-Score* “A valuable cross-device solution should enable partners to get everything they’re looking for from a single vendor,” said Tapad Founder and CEO, Are Traasdahl. “We are deeply impressed with how thorough Hotels.com was in their vetting, and we confidently tackle the complex challenges of the martech industry thanks to our superior technology. Everyone loves a bake-off, and Tapad is no exception – delivering best-in-class results in areas that really count.” *F-score is a statistical measurement that takes precision and recall together. The calculation is 2*(precision*recall)/precision + recall). It gives you one number instead of two numbers to look at and judge performance. Contact us today